Improving medication adherence for diabetes through behavioral science methods
Refinement and Testing of Recruitment Methodology for Behavioral Medication Adherence Interventions Using Behavioral Science-based Approaches
This study is testing different ways to help diabetes patients stick to their medication by using behavioral science techniques to see what works best.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 584 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Brigham and Women's Hospital Academic / other |
| Locations | 1 site (Boston, Massachusetts) |
| Trial ID | NCT06569290 on ClinicalTrials.gov |
What this trial studies
This research aims to enhance the implementation and dissemination of a clinical pharmacist intervention designed to improve medication adherence among diabetes patients. Utilizing a Type 3 Hybrid design, the study will primarily test various behavioral science-informed recruitment methods while also observing their clinical effects. Participants will be recruited from community settings and will include English or Spanish-speaking adults who are non-adherent to their prescribed glucose-lowering medications. The study builds on previous successful interventions and seeks to identify the most effective recruitment strategies for broader application.
Who should consider this trial
Good fit: Ideal candidates are English or Spanish-speaking adults aged 18 and older who are receiving care from a BMC primary care provider and are non-adherent to their prescribed oral glucose-lowering medications.
Not a fit: Patients with terminal conditions are unlikely to benefit from this study.
Why it matters
Potential benefit: If successful, this study could significantly improve medication adherence among diabetes patients, leading to better health outcomes.
How similar studies have performed: Previous studies, such as the STIC2IT trial, have shown success with similar behavioral science approaches to improve medication adherence.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * ≥18 years of age * English or Spanish speaking * Receiving care from a BMC primary care provider * Non-adherent to prescribed oral glucose-lowering medications as per pharmacy dispense records (proportion of days covered \<80% to at least one eligible medication in last 6 months) * Evidence of poor or worsening disease control Exclusion Criteria: * Evidence of terminal conditions
Where this trial is running
Boston, Massachusetts
- Boston Medical Center — Boston, Massachusetts, United States (Recruiting)
Study contacts
- Principal investigator: Niteesh K Choudhry, MD, PhD — Brigham and Women's Hospital
- Study coordinator: Niteesh K Choudhry, MD, PhD
- Email: nkchoudhry@bwh.harvard.edu
- Phone: (617) 278-0930
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.